Rus, L.M.; Uncu, A.; Parii, S.; Uifălean, A.; Hegheș, S.C.; Iuga, C.A.; Tomuță, I.; Mazur, E.; Șepeli, D.; Kacso, I.;
et al. Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss. Pharmaceutics 2025, 17, 1017.
https://doi.org/10.3390/pharmaceutics17081017
AMA Style
Rus LM, Uncu A, Parii S, Uifălean A, Hegheș SC, Iuga CA, Tomuță I, Mazur E, Șepeli D, Kacso I,
et al. Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss. Pharmaceutics. 2025; 17(8):1017.
https://doi.org/10.3390/pharmaceutics17081017
Chicago/Turabian Style
Rus, Lucia Maria, Andrei Uncu, Sergiu Parii, Alina Uifălean, Simona Codruța Hegheș, Cristina Adela Iuga, Ioan Tomuță, Ecaterina Mazur, Diana Șepeli, Irina Kacso,
and et al. 2025. "Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss" Pharmaceutics 17, no. 8: 1017.
https://doi.org/10.3390/pharmaceutics17081017
APA Style
Rus, L. M., Uncu, A., Parii, S., Uifălean, A., Hegheș, S. C., Iuga, C. A., Tomuță, I., Mazur, E., Șepeli, D., Kacso, I., Macaev, F., Valica, V., & Uncu, L.
(2025). Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss. Pharmaceutics, 17(8), 1017.
https://doi.org/10.3390/pharmaceutics17081017
